UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma

Science translational medicine, 2019-06, Vol.11 (496)

2019

Volltextzugriff (PDF)

Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Database

Clinical breast cancer, 2024-10, Vol.24 (7), p.647-659.e4

2024

Volltextzugriff (PDF)

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Journal of clinical oncology, 2020-02, Vol.38 (6), p.567-575

2020

Volltextzugriff (PDF)

Mcc1229, an Stx2a-Amplifying Microcin, Is Produced In Vivo and Requires CirA for Activity

Infection and immunity, 2022-02, Vol.90 (2), p.e0058721-e0058721

2022

Volltextzugriff (PDF)

Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years

Hematology (Luxembourg), 2018-01, Vol.23 (1), p.17-24

2018

Volltextzugriff (PDF)

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

Oncotarget, 2017-11, Vol.8 (58), p.99161-99178

2017

Volltextzugriff (PDF)

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research, 2016-01, Vol.2016 (10), p.103-106

2016

Volltextzugriff (PDF)

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients

PloS one, 2017-01, Vol.12 (1), p.e0168550

2017

Volltextzugriff (PDF)

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

Cancer biology & therapy, 2017-07, Vol.18 (7), p.451-469

2017

Volltextzugriff (PDF)

Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

Journal of oncology pharmacy practice, 2017-12, Vol.23 (8), p.620-624

2017

Volltextzugriff (PDF)

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

The New England journal of medicine, 1999-12, Vol.341 (27), p.2061-2067

1999

Volltextzugriff (PDF)

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1965-1971

2008

Volltextzugriff (PDF)

Role of EZH2 histone methyltrasferase in melanoma progression and metastasis

Cancer biology & therapy, 2016-06, Vol.17 (6), p.579-591

2016

Volltextzugriff (PDF)

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors

Journal for immunotherapy of cancer, 2024-07, Vol.12 (7), p.e008989

2024

Volltextzugriff (PDF)

Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5452-5458

2009

Volltextzugriff (PDF)

Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2157-2162

2009

Volltextzugriff (PDF)

Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination

Cancer Immunology, Immunotherapy, 2016-05, Vol.65 (5), p.563-573

2016

Volltextzugriff (PDF)

Consistency Between State's Cancer Registry and All-Payer Claims Database in Documented Radiation Therapy Among Patients Who Received Breast Conservative Surgery

JCO clinical cancer informatics, 2023-01, Vol.7 (7), p.e2200099

2023

Volltextzugriff (PDF)

A Prospective Analysis of the Influence of Older Age on Physician and Patient Decision‐Making When Considering Enrollment in Breast Cancer Clinical Trials (SWOG S0316)

The oncologist (Dayton, Ohio), 2012-09, Vol.17 (9), p.1180-1190

2012

Volltextzugriff (PDF)

Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm

Digestive diseases and sciences, 2016-07, Vol.61 (7), p.2132-2139

2016

Volltextzugriff (PDF)

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002535

2021

Volltextzugriff (PDF)

Cancer survivorship training: a pilot study examining the educational gap in primary care medicine residency programs

Journal of cancer survivorship, 2014-12, Vol.8 (4), p.565-570

2014

Volltextzugriff (PDF)

Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study

Frontiers in oncology, 2020-06, Vol.10, p.879-879

2020

Volltextzugriff (PDF)

Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8313-8321

2005

Volltextzugriff (PDF)

Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1223-1230

2008

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(231)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(137)
Humans
(114)
Female
(85)
Oncology
(82)
Middle Aged
(68)
Aged
(58)
Adult
(55)
Biological And Medical Sciences
(52)
Medical Sciences
(51)
Male
(48)
Tumors
(28)
Aged, 80 And Over
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Breast Neoplasms - Drug Therapy
(24)
Breast Cancer
(22)
Pharmacology. Drug Treatments
(21)
Treatment Outcome
(21)
Antineoplastic Agents
(20)
Chemotherapy
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma

Racial Disparity in Adherence to Endocrine Therapy among Women with Early-Stage Hormone Receptor Positive Breast Cancer: An Analysis of Arkansas All-Payers Claims Database

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Mcc1229, an Stx2a-Amplifying Microcin, Is Produced In Vivo and Requires CirA for Activity

Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients

Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack

Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial

Role of EZH2 histone methyltrasferase in melanoma progression and metastasis

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors

Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma

Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897

Human papillomavirus type 16 viral load is decreased following a therapeutic vaccination

Consistency Between State's Cancer Registry and All-Payer Claims Database in Documented Radiation Therapy Among Patients Who Received Breast Conservative Surgery

A Prospective Analysis of the Influence of Older Age on Physician and Patient Decision‐Making When Considering Enrollment in Breast Cancer Clinical Trials (SWOG S0316)

Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Cancer survivorship training: a pilot study examining the educational gap in primary care medicine residency programs

Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study

Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102

Late Cardiac Effects of Adjuvant Chemotherapy in Breast Cancer Survivors Treated on Southwest Oncology Group Protocol S8897

Suchergebnisse filtern